Endovascular stents for dialysis access: under what circumstances do the data support their use?
Despite strict K/DOQI clinical practice guidelines regarding the deployment of stents in the hemodialysis vascular circuit, their use has increased exponentially over the last 10 years in both arteriovenous fistulas and grafts. The literature is very scant regarding outcomes, with most studies suffering from design flaws. Some authors have advocated the use of stents for specific clinical scenarios, such as patients with thrombosed arteriovenous grafts or ones with a severe stenosis at the venous anastomosis. Others have advocated a more liberal strategy to deploy stents at a variety of sites if the stenotic lesion remains greater than 30% after angioplasty. Although not approved for the treatment of pseudoaneurysms in the AV grafts, stent use in this setting is emerging to be an important strategy. The use of stents as a treatment for rupture of a vessel while performing a percutaneous angioplasty is well described and performed routinely. It is important to recognize the clinical scenarios when stent placement may present a distinct disadvantage (eg, loss of a potential secondary fistula creation in the same extremity). Finally, well-designed studies need to address all these issues to clarify indications and to provide stronger scientific guidelines for stent use.
Yevzlin
Alexander S
AS
Department of Interventional Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53713, USA. asy@medicine.wisc.edu
Maya
Ivan D
ID
Asif
Arif
A
D017541:Aneurysm, False / Q000601:surgery; D001166:Arteriovenous Shunt, Surgical; D006801:Humans; D006435:Renal Dialysis / Q000295:instrumentation*; D015607:Stents